Dianthus Therapeutics (DNTH) Change in Acquisitions & Divestments (2019 - 2025)

Dianthus Therapeutics' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $78.6 million for Q3 2025.

• In Q3 2025, Change in Acquisitions & Divestments rose 313.53% year-over-year to $78.6 million; the TTM figure through Sep 2025 stood at $305.3 million (up 408.86% YoY), while the FY2024 annual figure was $127.0 million, up 63.27% from the prior year.
• Change in Acquisitions & Divestments was $78.6 million for Q3 2025 at Dianthus Therapeutics, up from $59.6 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $85.0 million in Q4 2024 to a low of $2.0 million in Q4 2022.
• Historically, Change in Acquisitions & Divestments has averaged $32.3 million across 5 years, with a median of $20.4 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 94.29% in 2022, then surged 800.0% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $35.0 million in 2021, then slumped by 94.29% to $2.0 million in 2022, then soared by 800.0% to $18.0 million in 2023, then surged by 372.22% to $85.0 million in 2024, then retreated by 7.56% to $78.6 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $78.6 million (Q3 2025), $59.6 million (Q2 2025), and $82.1 million (Q1 2025), per Business Quant data.